Completion Of A Non-Exclusive Discount Contract According To Section 130C Paragraph 1 Sgb V For Doravirin, Lamivudine, Tenofovir Disoproxil Fumarate, Atc Code: J05Ar24 For The Period From December 1St, 2023 To November 30Th, 2025

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 73970446

  Document Type - Tender Notices

Description - This announcement serves to conclude drug discount agreements in accordance with Section 130a Paragraph 8 SGB V for the active ingredient(s) mentioned under point II.1.1). This does not involve the awarding of public contracts within the meaning of D irective 2014/24/EU or Sections 97 ff GWB. Any pharmaceutical company can become a contractual partner in accordance with Section 4 Paragraph 18 AMG. According to the case law of the ECJ, such approval procedures are not necessarily subject to public procurement law, since no competition takes place due to the lack of a selection decision. The announcement serves as an invitation to conclude discount agreements with conditions that apply equally

Gt Ref Id - 73970446

Deadline - Oct 03, 2025